Instalab

Lamb's Quarter Weed (Che a 1) IgE Test Blood

Pinpoint whether lamb's quarter pollen is driving your hay fever or asthma, beyond what a general allergy panel shows.

Should you take a Lamb's Quarter Weed (Che a 1) IgE test?

This test is most useful if any of these apply to you.

Struggling With Late Summer Allergies
If your symptoms peak when weeds bloom, this test can confirm whether lamb's quarter pollen is one of the triggers behind your reaction.
Living With Asthma or Hay Fever
If you already have respiratory allergies, identifying the specific pollens you react to helps you plan medication timing and exposure avoidance.
Considering Allergy Immunotherapy
If you are weighing allergy shots or drops, knowing the exact pollen proteins driving your symptoms helps target treatment to what is actually causing them.
Living in a Dry or Weedy Region
If you live somewhere weeds thrive, like dry climates or areas with disturbed soil, this test screens for one of the most common pollen allergies in those settings.

About Lamb's Quarter Weed (Che a 1) IgE

If your nose runs every late summer and you cannot figure out why, the culprit may be a weed most people walk past without noticing. Lamb's quarter (Chenopodium album) is one of the most common weeds in North America, and its pollen is a major driver of seasonal allergy in many parts of the world, especially in dry climates.

This test looks for IgE (immunoglobulin E) antibodies your immune system has made against Che a 1, a specific protein in lamb's quarter pollen. If those antibodies are present, it means your immune system has been primed to react when you breathe in this pollen, which can show up as hay fever, itchy eyes, or asthma symptoms during weed pollen season.

What This Test Actually Measures

Che a 1 is a plant protein found in lamb's quarter pollen, part of a family of weed and tree pollen proteins called Ole e 1-like allergens. The pollen makes the protein. Your body does not. What this blood test measures is the level of human IgE antibodies your immune system has produced against that plant protein.

IgE is the antibody class your body uses for allergic reactions. When IgE recognizes an allergen like Che a 1, it attaches to immune cells called mast cells and basophils. The next time you inhale lamb's quarter pollen, those cells release histamine and other chemicals, producing the familiar allergy symptoms. A positive Che a 1 IgE result tells you this priming has happened. It does not tell you, on its own, how severe your symptoms will be.

Why Lamb's Quarter Allergy Matters

Lamb's quarter is part of the Chenopodiaceae plant family, which research describes as a major cause of pollen allergy in desert and dry-climate regions, with rising importance worldwide. Population-based research in dry-climate regions has found lamb's quarter pollen to be among the most common inhalant sensitizers, alongside grasses and house dust mite.

If you live somewhere where weeds thrive in disturbed soil, vacant lots, gardens, and roadsides, lamb's quarter is probably nearby. The pollen is wind-carried and easy to inhale during late summer and fall.

Allergic Rhinitis and Asthma

Sensitization to lamb's quarter pollen is part of the broader picture of weed-pollen allergy linked to allergic rhinitis (hay fever) and asthma. In population-based work using IgE profiles across many pollen components, sensitization patterns to weed proteins like Che a 1 contribute, along with grass, tree, and mite sensitizations, to defining who is at risk for these respiratory conditions.

Knowing exactly which pollens you react to changes the conversation. It helps you anticipate symptom seasons, decide when to start allergy medications, choose where to spend time outdoors, and decide whether allergen-specific immunotherapy targeting this weed family is worth exploring with a specialist.

Distinguishing One Weed From Another

Lamb's quarter shares its plant family with Russian thistle (Salsola kali), and people often react to both. But not always. Some people show IgE only to Russian thistle. The reason is that each weed has signature proteins. A Russian thistle-specific protein called Sal k 1 marks pure Salsola sensitization, while Che a 1 marks lamb's quarter sensitization. This is why testing for individual proteins, rather than just a crude weed-pollen mix, can change what you do next.

If your standard weed panel comes back positive but does not break out the specific protein, you may not know whether avoidance or immunotherapy should target lamb's quarter, Russian thistle, or both.

What the Number Means

A positive Che a 1 IgE result confirms sensitization: your immune system has produced antibodies against this specific lamb's quarter protein. Sensitization is not the same as clinical allergy. Some people carry IgE to an allergen and never develop symptoms when exposed. The result is most useful when paired with your actual experience. If you have late-summer hay fever and a positive Che a 1 IgE, the diagnosis becomes much clearer.

A negative or low result means your immune system has not produced detectable IgE to this particular protein. It does not rule out allergy to other weeds, grasses, mites, animals, or molds. If your symptoms are real but Che a 1 IgE is negative, the cause likely lies elsewhere, and a broader allergen panel may be the next step.

Tracking Your Trend

A single IgE reading captures a snapshot of your immune system at one moment. Sensitization patterns can shift with age, repeated exposure, and treatment. If you start allergen immunotherapy or move to a new climate, tracking your specific IgE over time can show whether the underlying immune signal is changing.

A reasonable approach: get a baseline reading when symptoms are active or shortly after a high-pollen season, retest in 6 to 12 months if you are doing something to address it (avoidance, medication, or immunotherapy), then at least annually if you want to track your trajectory. Compare results from the same lab and same assay, since methods differ.

If Your Result Is Positive

A positive Che a 1 IgE result is not a crisis. It is information. The decision pathway depends on whether you have symptoms and how disruptive they are. If you have clear seasonal symptoms aligned with weed pollen, this result supports a diagnosis of lamb's quarter allergy and gives you something concrete to act on. Consider ordering companion tests for related weeds (Russian thistle / Sal k 1), grasses, and trees common in your region to map the full allergen picture.

If symptoms are significant, an allergist can use the molecular pattern to decide whether allergen-specific immunotherapy is appropriate and which extracts to use. If the result is positive but you have no symptoms, no treatment is needed. The result is useful background if symptoms develop later.

When Results Can Be Misleading

A few things can complicate interpretation of specific IgE testing in general:

  • Cross-reactivity from panallergens: some pollen proteins are similar across plant species, so IgE made against one plant can show up on tests for a related plant. Cyclophilins, profilins, and similar cross-reactive proteins can produce positive specific-IgE results that do not always mean clinical allergy to that exact plant.
  • Sensitization without symptoms: detectable IgE does not always mean you will have symptoms. The result is most meaningful when interpreted alongside your actual exposures and symptom history.
  • Assay differences: different lab platforms can give different absolute numbers for the same sample. Trend interpretation works best when results come from the same method.
  • Polysensitization: many people react to multiple allergens. A positive Che a 1 result does not tell you which allergen is doing the most damage in your daily life. That requires correlating results with seasonal symptoms.

Frequently Asked Questions

References

6 studies
  1. Ezeamuzie C, Al-mousawi M, Dashti H, Al-bashir a, Al-hage M, Al-ali SAllergy1997
  2. Barderas R, Garcia-selles J, Salamanca G, Colas C, Barber D, Rodriguez R, Villalba MClinical & Experimental Allergy2007
  3. Dsouza N, Weber M, Sarzsinszky E, Vrtala S, Curin M, Schaar M, Garib V, Focke-tejkl M, Li Y, Jones R, Chen H, Valenta R, Sun BFrontiers in Immunology2021
  4. Scala E, Caprini E, Abeni D, Giorgia M, Buzzulini F, Cecchi L, Villalta D, Asero RClinical & Experimental Allergy2021